Similar observations were obtained for pre-treatment CRP by Nakamu et al, the elevated levels of pre-treatment CRP are demonstrated to be correlated with a decreased disease-specific survival and an increased rate of local recurrence in patients with a sarcoma of bone [5]. Here, CRP is linked to sarcoma.